ARNA Overview
Upcoming Projects (ARNA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ARNA)
-
A look at the potential of S1P modulators in moderate-severe ulcerative colitis and how they might fit into the treatment paradigm
Tickers: ARNA, BMY, CNTB
Executed On: Mar 07, 2022 at 12:00 PM EST
Expired Projects (ARNA)
-
Analyzing the recent Phase 2 Etrasimod data and comparing it to Celgene's ozanimod in ulcerative colitis patients
Tickers: ARNA, CELG
Execute By: Mar 23, 2018
Upcoming & Overdue Catalysts (ARNA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ARNA)
-
FDA Grants Fast Track Designation to Arena Pharmaceuticals' (ARNA) APD418 for Development in Decompensated Heart Failure Patients
Ticker: ARNA
Occurred on: Jan 16, 2020 -
APD334 (Etrasimod) in treating Ulcerative colitis Phase 2 data due Q1 2018
Ticker: ARNA
Occurred on: Mar 19, 2018 -
Data from Etrasimod Optimized Activity SIP Receptor Modulator in Treating Ulcerative Colitis expected Q4 2017
Ticker: ARNA
Occurred on: Nov 10, 2017 -
Phase 2 data of Ralinepag (APD811) in treating Pulmonary Arterial hypertension expected mid 2017
Ticker: ARNA
Occurred on: Jul 10, 2017 -
APD371 in treating Pain associated with Crohn's Disease Phase 2 to be initiated in Q1 2017
Ticker: ARNA
Occurred on: May 09, 2017 -
Arena Pharma (ARNA) Prices Public Equity Offering of 60M Common Shares at $1.15 Per Share
Ticker: ARNA
Occurred on: Apr 17, 2017 -
Eisai (ESALY) and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR (lorcaserin HCl) Extended-Release Tablets
Ticker: ARNA
Occurred on: Jul 19, 2016
Strategic Initiatives (ARNA)
-
Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia
Ticker: ARNA
Announcement Date: Jan 12, 2016
